Patients who take osteoporosis drugs for long periods typically are advised to temporarily discontinue the drugs to prevent rare but serious side effects to the jaw and thighs.
May 4, 2018
0
4
(HealthDay)—Women and men below age 70 who are treated for osteoporosis have an excess mortality risk, according to a study published online Feb. 7 in the Journal of Bone and Mineral Research.
Feb 13, 2015
0
38
(HealthDay)—Many osteoporosis drugs cut women's risk of suffering a bone fracture, though it's not clear whether any one medication works better than others, a new research review finds.
Sep 9, 2014
0
0
(HealthDay)—Taking osteoporosis drugs called bisphosphonates to help prevent fractures may carry a slight risk for unusual breaks in the thigh bone, Swedish researchers report.
Sep 4, 2014
0
1
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco (UCSF).
Aug 11, 2014
0
0
What dictates the shape of a person's hips and spine is being examined in a new study by University of Aberdeen scientists.
Mar 10, 2014
0
0
Scientists from the University of Granada (UGR) have opened the door to the development of new drugs against osteoporosis, one of the most common chronic illnesses in the world, especially among women 65 or over.
Mar 5, 2014
0
0
Doctors commonly recommend drug holidays, or breaks, from certain osteoporosis drugs due to the risks associated with these treatments. Yet little has been known about the ideal duration of the holidays and how best to manage ...
Jan 15, 2014
0
0
A committee of Europe's medicines watchdog on Friday recommended suspending the use of an osteoporosis drug, saying the risks, including heart attacks, outweighed the benefits.
Jan 10, 2014
0
0
A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic ...
Nov 28, 2013
0
0
